00078-0874 Kisqali - CanMED: NDC

Product NDC:

00078-0874

Brand Name:

Kisqali

Generic Name:

Ribociclib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: RIBOCICLIB

Strength: 200.0

Unit: mg/1

Name: RIBOCICLIB SUCCINATE

Strength: 200.0

Unit: mg/1

Packages:

Code: 00078-0874-21

Description:

Effective Date: March 13, 2017

Discontinued:

Code: 00078-0874-63

Description: 3 BLISTER PACK in 1 CARTON (0078-0874-63) / 21 TABLET, FILM COATED in 1 BLISTER PACK (0078-0874-21)

Effective Date: March 13, 2017

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Cyclin Dependent Kinase Inhibitor

Minor Class:

CDK 4/6

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox